Solstein Capital’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.1K	Hold	4,477	–	–	0.01%	301
2025 Q4	$17.1K	Hold	4,477	–	–	0.01%	288
2025 Q3	$14.5K	Hold	4,477	–	–	﹤0.01%	304
2025 Q2	$12.9K	Hold	4,477	–	–	0.01%	319
2025 Q1	$9.63K	Hold	4,477	–	–	0.01%	239
2024 Q4	$17.3K	Hold	4,477	–	–	0.01%	214
2024 Q3	$29.3K	Hold	4,477	–	–	0.02%	179
2024 Q2	$32.5K	Hold	4,477	–	–	0.02%	164
2024 Q1	$34K	Hold	4,477	–	–	0.02%	161
2023 Q4	$20.4K	Hold	4,477	–	–	0.02%	186
2023 Q3	$17.7K	Hold	4,477	–	–	0.02%	190
2023 Q2	$14K	Hold	4,477	–	–	0.01%	205
2023 Q1	$20.3K	Hold	4,477	–	–	0.02%	164
2022 Q4	$18.5K	Hold	4,477	–	–	0.02%	180
2022 Q3	$14K	Hold	4,477	–	–	0.01%	211
2022 Q2	$9K	Hold	4,477	–	–	0.01%	263
2022 Q1	$18K	Hold	4,477	–	–	0.01%	257
2021 Q4	$48K	Hold	4,477	–	–	0.03%	218
2021 Q3	$52K	Hold	4,477	–	–	0.03%	228
2021 Q2	$44K	Hold	4,477	–	–	0.05%	228
2021 Q1	$65K	Buy	+4,477	New	+$81.3K	0.09%	192